$25.610
-0.635 (-2.48%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RARE Prediction & Forecast by Similar Chart Analysis
Alphio's RARE stock price prediction model matches the current Ultragenyx Pharmaceutical Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.71 (+0.38%). The 1-week path is $25.03 (-2.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Ultragenyx Pharmaceutical Inc Stock?
Ultragenyx Pharmaceutical Inc. (RARE) is a good buy right now due to its recent FDA accelerated approval for GENGLYCOS, which is expected to significantly enhance revenue potential. The current price is $25.61, and analysts have set price targets as high as $103, indicating substantial upside potential. Additionally, the gross margin stands at 84.11%, reflecting strong profitability potential despite current losses. However, the main risk is the negative net income, which was -92 million USD in the latest quarter, indicating ongoing financial challenges.
RARE stock price ended at $25.61 on Friday, after losing -2.48%
Ultragenyx Pharmaceutical Inc (RARE) last closed at $25.61, losing -2.48%. These facts feed the 1-day and 1-week RARE price prediction above.
Analyst Consensus
Ultragenyx Pharmaceutical Inc (RARE): 10 buy, 7 hold, 1 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Ultragenyx Pharmaceutical Inc (RARE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches RARE, ranked by similarity.
Seasonality analysis for RARE
Historically the probability of a positive August return for RARE is 65.08%. August offers the highest probability of a positive month at 65.08%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RARE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $48.46 | $51.38 | $55.27 | +100.61% |
| Sep 2026 | $37.62 | $41.80 | $47.67 | +63.21% |
| Oct 2026 | $43.78 | $51.74 | $56.68 | +102.03% |
| Nov 2026 | $50.96 | $51.74 | $51.97 | +102.03% |
| Dec 2026 | $49.40 | $49.73 | $52.29 | +94.19% |
In 2026, Ultragenyx Pharmaceutical Inc (RARE) is projected to range from $37.62 to $56.68.
Ultragenyx Pharmaceutical Inc 2026 monthly forecast
In Aug 2026, Ultragenyx Pharmaceutical Inc is projected to average $51.38, with a low of $48.46 and high of $55.27.
In Sep 2026, Ultragenyx Pharmaceutical Inc is projected to average $41.80, with a low of $37.62 and high of $47.67.
In Oct 2026, Ultragenyx Pharmaceutical Inc is projected to average $51.74, with a low of $43.78 and high of $56.68.
In Nov 2026, Ultragenyx Pharmaceutical Inc is projected to average $51.74, with a low of $50.96 and high of $51.97.
In Dec 2026, Ultragenyx Pharmaceutical Inc is projected to average $49.73, with a low of $49.40 and high of $52.29.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.